Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.52p
   
  • Change Today:
    -0.18p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 762,667
  • Market Cap: £32.78m
  • RiskGrade: 328
  • Beta: 1.20

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £97,048
Lisa Baderoon 583,963 £38,074
Tim Franklin 525,000 £34,230

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,637,044
Invesco Ltd 17,872,341 £1,165,277
Aviva Investors Global 11,285,180 £735,794
Alora Pharmaceuticals LLC 10,909,091 £711,273
M&G Investments 7,600,000 £495,520
Prudential plc 7,600,000 £495,520
Capital Income Builder 4,870,367 £317,548
Dr R Zimmer 4,551,553 £296,761
Odey Asset Management 3,433,319 £223,852
Rhone Trustees (Switzerland) SA 3,386,000 £220,767
Pictet Overseas Trust Corporation Limited 3,287,500 £214,345

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.52p
Change Today -0.18p
% Change -2.69 %
52 Week High 17.60
52 Week Low 1.50
Volume 762,667
Shares Issued 502.72m
Market Cap £32.78m
Beta 1.20
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 19-Jan-2026

Time Volume / Share Price
11:45 5,000 @ 6.55p
11:44 8,119 @ 6.75p
11:37 340 @ 6.98p
11:37 50,600 @ 6.52p
11:37 10,000 @ 6.52p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page